Vir Biotechnology stockVIR
Vir Biotechnology trades at $11.02, 9.6% below its 52-week high (Oct 29, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +82.8% year to date, +104.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for VIR — after you log in
Open the terminalFrequently asked questions about Vir Biotechnology
What is the Vir Biotechnology stock price?
At the close on Nov 5, 2026: $11.02 (−6.37% on the day). 52-week high: $12.19 on Oct 29, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Vir Biotechnology report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +51% year over year, revenue −178%.
Does Vir Biotechnology pay dividends?
No, Vir Biotechnology does not pay dividends.
Where does Vir Biotechnology trade and how to buy it?
Ticker VIR, exchange Nasdaq, listed since 2019. You can buy it through a broker with access to US exchanges.
Should I buy Vir Biotechnology now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for VIR are in the terminal after you log in.